This topic should be handled carefully and responsibly
Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice
Gasbjerg LS, Hartmann B, Christensen MB, Lanng AR, Vilsbll T, Jrgensen NR, et al
Lower-cost medication alternatives: When Medicaid does not cover weight loss shots, providers can consider covered alternatives such as phentermine, orlistat, or naltrexone/bupropion, which may be on the state formulary even when GLP-1s are excluded
If a dose is missed, do not double the next injection unless a healthcare professional gives that instruction